Matches in SemOpenAlex for { <https://semopenalex.org/work/W1915030180> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1915030180 startingPage "3401" @default.
- W1915030180 abstract "ADC3680 is a potent and selective CRTh2 antagonist whose efficacy is currently being evaluated in subjects with uncontrolled asthma on ICS. In Phase I, 88 healthy volunteers were exposed to ≥1 dose of ADC3680 (1 – 200 mg as single doses; 10, 30 and 90 mg once daily for 7 days; and 10 mg daily for 14 days). 24 further subjects with partly controlled atopic asthma on ICS, received a 22.73 mg ADC3680 once daily for 28 days. ADC3680 is relatively rapidly absorbed (t max 2.5 hrs) and suitable for once-daily oral dosing (t 1/2 11–15 hrs). Total plasma clearance of ADC3680 is low with little evidence of accumulation on repeat dosing. ADC3680 was safe and well-tolerated at single doses up to 200 mg, at doses up to 90 mg administered once daily for 7 days and in post-menopausal female volunteers at a single dose of 25 mg. ADC3680 was also well-tolerated in atopic asthmatics (22.73 mg once daily for 28 days). Most adverse events reported were mild or moderate and were considered to be unrelated to treatment and there were no clinically significant changes in laboratory safety parameters. ADC3680 blocked PGD 2 mediated eosinophil shape change response (ESC) ex-vivo in blood from healthy and asthmatic subjects. >90% inhibition of ESC was observed with ADC3680 at single (1 to 200 mg) and multiple ADC3680 doses (10, 30, and 90 mg once daily for 7 days). In asthmatic subjects, ADC3680 (22.73 mg daily) blocked ESC by >95% 24 hours post-dose on Day 1, and at 24 and 48 hours post-dose after 28 days9 treatment. The overall PK, safety and PD profile of ADC3680 support its further development as a low dose (" @default.
- W1915030180 created "2016-06-24" @default.
- W1915030180 creator A5005491498 @default.
- W1915030180 creator A5005665828 @default.
- W1915030180 creator A5020515187 @default.
- W1915030180 creator A5023371834 @default.
- W1915030180 creator A5023586164 @default.
- W1915030180 creator A5063472703 @default.
- W1915030180 creator A5070084615 @default.
- W1915030180 date "2013-09-01" @default.
- W1915030180 modified "2023-09-26" @default.
- W1915030180 title "The safety, PK and PD profile of ADC3680, a potent and selective CRTh2 antagonist, in healthy volunteers and partly controlled atopic asthmatic subjects" @default.
- W1915030180 hasPublicationYear "2013" @default.
- W1915030180 type Work @default.
- W1915030180 sameAs 1915030180 @default.
- W1915030180 citedByCount "0" @default.
- W1915030180 crossrefType "journal-article" @default.
- W1915030180 hasAuthorship W1915030180A5005491498 @default.
- W1915030180 hasAuthorship W1915030180A5005665828 @default.
- W1915030180 hasAuthorship W1915030180A5020515187 @default.
- W1915030180 hasAuthorship W1915030180A5023371834 @default.
- W1915030180 hasAuthorship W1915030180A5023586164 @default.
- W1915030180 hasAuthorship W1915030180A5063472703 @default.
- W1915030180 hasAuthorship W1915030180A5070084615 @default.
- W1915030180 hasConcept C126322002 @default.
- W1915030180 hasConcept C170493617 @default.
- W1915030180 hasConcept C197934379 @default.
- W1915030180 hasConcept C2776042228 @default.
- W1915030180 hasConcept C2776885963 @default.
- W1915030180 hasConcept C2777037409 @default.
- W1915030180 hasConcept C2777288759 @default.
- W1915030180 hasConcept C71924100 @default.
- W1915030180 hasConcept C98274493 @default.
- W1915030180 hasConceptScore W1915030180C126322002 @default.
- W1915030180 hasConceptScore W1915030180C170493617 @default.
- W1915030180 hasConceptScore W1915030180C197934379 @default.
- W1915030180 hasConceptScore W1915030180C2776042228 @default.
- W1915030180 hasConceptScore W1915030180C2776885963 @default.
- W1915030180 hasConceptScore W1915030180C2777037409 @default.
- W1915030180 hasConceptScore W1915030180C2777288759 @default.
- W1915030180 hasConceptScore W1915030180C71924100 @default.
- W1915030180 hasConceptScore W1915030180C98274493 @default.
- W1915030180 hasLocation W19150301801 @default.
- W1915030180 hasOpenAccess W1915030180 @default.
- W1915030180 hasPrimaryLocation W19150301801 @default.
- W1915030180 hasRelatedWork W1528667565 @default.
- W1915030180 hasRelatedWork W1977402941 @default.
- W1915030180 hasRelatedWork W2010306947 @default.
- W1915030180 hasRelatedWork W2067866359 @default.
- W1915030180 hasRelatedWork W2091211837 @default.
- W1915030180 hasRelatedWork W2105624539 @default.
- W1915030180 hasRelatedWork W2194222775 @default.
- W1915030180 hasRelatedWork W2567003761 @default.
- W1915030180 hasRelatedWork W2583745276 @default.
- W1915030180 hasRelatedWork W2773164113 @default.
- W1915030180 hasRelatedWork W2898231052 @default.
- W1915030180 hasRelatedWork W2922294623 @default.
- W1915030180 hasRelatedWork W2989804726 @default.
- W1915030180 hasRelatedWork W3087267424 @default.
- W1915030180 hasRelatedWork W3089045575 @default.
- W1915030180 hasRelatedWork W3123402889 @default.
- W1915030180 hasRelatedWork W3169924475 @default.
- W1915030180 hasRelatedWork W3173329502 @default.
- W1915030180 hasRelatedWork W968300324 @default.
- W1915030180 hasRelatedWork W1931399433 @default.
- W1915030180 hasVolume "42" @default.
- W1915030180 isParatext "false" @default.
- W1915030180 isRetracted "false" @default.
- W1915030180 magId "1915030180" @default.
- W1915030180 workType "article" @default.